VAERS reports by lot

Seqirus / CSL Flu lot 195233: VAERS reports

35 VAERS reports list lot 195233 as a Seqirus / CSL Flu vaccine, received between 2017-10-16 and 2019-07-19. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
3%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3421%
Neurological3119%
Dermatological (non-injection-site)2314%
General / Systemic (non-local)1811%
Musculoskeletal138%
Allergic / Anaphylactic128%
Cardiac / Cardiovascular106%
Respiratory64%
Psychiatric / Neuropsychiatric64%
Thrombotic / Hematological42%
Gastrointestinal32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Florida5
Minnesota3
New Jersey3
New York3
South Carolina2
Missouri2
Virginia2
Georgia2
Pennsylvania2
Ohio1
New Hampshire1
North Carolina1

Reports by month received

2017-103
2017-1111
2017-1210
2018-013
2018-021
2018-031
2018-101
2019-014
2019-071

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.